Which has better valuation & earnings, ASTH or HNGE?

Astrana Health has higher revenue and earnings than Hinge Health. Astrana Health is trading at a lower price-to-earnings ratio than Hinge Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Astrana Health $3.18B 0.67 $22.49M $0.82 46.32 Hinge Health $587.86M 12.20 -$528.26M $1.28 69.42

Is CHE or ASTH more profitable?

Chemed has a net margin of 10.60% compared to Astrana Health's net margin of 1.05%. Chemed's return on equity of 31.77% beat Astrana Health's return on equity. Company Net Margins Return on Equity Return on Assets Chemed 10.60% 31.77% 18.90% Astrana Health 1.05% 10.30% 3.67%

Which has higher earnings & valuation, ASTH or RDNT?

Astrana Health has higher revenue and earnings than RadNet. RadNet is trading at a lower price-to-earnings ratio than Astrana Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Astrana Health $3.18B 0.67 $22.49M $0.82 46.32 RadNet $2.04B 2.91 -$18.65M -$0.27 N/A

Is ASTH or RDNT more profitable?

Astrana Health has a net margin of 1.05% compared to RadNet's net margin of -0.93%. Astrana Health's return on equity of 10.30% beat RadNet's return on equity. Company Net Margins Return on Equity Return on Assets Astrana Health 1.05% 10.30% 3.67% RadNet -0.93% 2.61% 0.91%

Astrana Health (ASTH) Competitors

$37.98 -0.05 (-0.13%)

Closing price 09/11/2026 04:00 PM Eastern

Extended Trading

$38.02 +0.05 (+0.12%)

As of 09/11/2026 07:30 PM Eastern

Compare

ASTH vs. HNGE, CHE, HIMS, RDNT, and LFST

Should you buy Astrana Health stock or one of its competitors? Astrana Health's main competitors and comparable companies include Hinge Health (HNGE), Chemed (CHE), Hims & Hers Health (HIMS), RadNet (RDNT), and LifeStance Health Group (LFST). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does Astrana Health compare to Hinge Health?

Astrana Health (NASDAQ:ASTH) and Hinge Health (NYSE:HNGE) are both mid-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, profitability, risk, analyst recommendations, media sentiment, institutional ownership, dividends and earnings.

Hinge Health has a net margin of 15.15% compared to Astrana Health's net margin of 1.05%. Hinge Health's return on equity of 51.60% beat Astrana Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Astrana Health	1.05%	10.30%	3.67%
Hinge Health	15.15%	51.60%	14.16%

Astrana Health has a beta of 0.9, suggesting that its share price is 10% less volatile than the broader market. Comparatively, Hinge Health has a beta of 1.38, suggesting that its share price is 38% more volatile than the broader market.

Astrana Health has higher revenue and earnings than Hinge Health. Astrana Health is trading at a lower price-to-earnings ratio than Hinge Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Astrana Health	$3.18B	0.67	$22.49M	$0.82	46.32
Hinge Health	$587.86M	12.20	-$528.26M	$1.28	69.42

Astrana Health presently has a consensus price target of $49.43, suggesting a potential upside of 30.14%. Hinge Health has a consensus price target of $101.93, suggesting a potential upside of 14.71%. Given Astrana Health's higher probable upside, equities research analysts clearly believe Astrana Health is more favorable than Hinge Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Astrana Health	0 Sell rating(s)	2 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.78
Hinge Health	1 Sell rating(s)	2 Hold rating(s)	14 Buy rating(s)	1 Strong Buy rating(s)	2.83

52.8% of Astrana Health shares are held by institutional investors. 20.3% of Astrana Health shares are held by company insiders. Comparatively, 18.9% of Hinge Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

In the previous week, Hinge Health had 10 more articles in the media than Astrana Health. MarketBeat recorded 11 mentions for Hinge Health and 1 mentions for Astrana Health. Astrana Health's average media sentiment score of 1.89 beat Hinge Health's score of 0.29 indicating that Astrana Health is being referred to more favorably in the media.

Company	Overall Sentiment
Astrana Health	Very Positive
Hinge Health	Neutral

Summary

Hinge Health beats Astrana Health on 11 of the 17 factors compared between the two stocks.

How does Astrana Health compare to Chemed?

Chemed (NYSE:CHE) and Astrana Health (NASDAQ:ASTH) are both mid-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, earnings, risk, media sentiment, institutional ownership, profitability, analyst recommendations and valuation.

Chemed has a beta of 0.51, indicating that its stock price is 49% less volatile than the broader market. Comparatively, Astrana Health has a beta of 0.9, indicating that its stock price is 10% less volatile than the broader market.

In the previous week, Chemed had 7 more articles in the media than Astrana Health. MarketBeat recorded 8 mentions for Chemed and 1 mentions for Astrana Health. Astrana Health's average media sentiment score of 1.89 beat Chemed's score of 1.09 indicating that Astrana Health is being referred to more favorably in the news media.

Company	Overall Sentiment
Chemed	Positive
Astrana Health	Very Positive

Chemed has higher earnings, but lower revenue than Astrana Health. Chemed is trading at a lower price-to-earnings ratio than Astrana Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Chemed	$2.53B	2.66	$265.24M	$19.91	25.87
Astrana Health	$3.18B	0.67	$22.49M	$0.82	46.32

Chemed has a net margin of 10.60% compared to Astrana Health's net margin of 1.05%. Chemed's return on equity of 31.77% beat Astrana Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Chemed	10.60%	31.77%	18.90%
Astrana Health	1.05%	10.30%	3.67%

Chemed presently has a consensus target price of $530.75, indicating a potential upside of 3.02%. Astrana Health has a consensus target price of $49.43, indicating a potential upside of 30.14%. Given Astrana Health's stronger consensus rating and higher probable upside, analysts plainly believe Astrana Health is more favorable than Chemed.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Chemed	0 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.17
Astrana Health	0 Sell rating(s)	2 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.78

95.9% of Chemed shares are owned by institutional investors. Comparatively, 52.8% of Astrana Health shares are owned by institutional investors. 3.3% of Chemed shares are owned by company insiders. Comparatively, 20.3% of Astrana Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

Chemed and Astrana Health tied by winning 8 of the 16 factors compared between the two stocks.

How does Astrana Health compare to Hims & Hers Health?

Hims & Hers Health (NYSE:HIMS) and Astrana Health (NASDAQ:ASTH) are both mid-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, dividends, media sentiment, institutional ownership, valuation, risk, analyst recommendations and earnings.

Hims & Hers Health has a beta of 2.42, indicating that its stock price is 142% more volatile than the broader market. Comparatively, Astrana Health has a beta of 0.9, indicating that its stock price is 10% less volatile than the broader market.

63.5% of Hims & Hers Health shares are held by institutional investors. Comparatively, 52.8% of Astrana Health shares are held by institutional investors. 11.8% of Hims & Hers Health shares are held by company insiders. Comparatively, 20.3% of Astrana Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Hims & Hers Health has higher earnings, but lower revenue than Astrana Health. Hims & Hers Health is trading at a lower price-to-earnings ratio than Astrana Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hims & Hers Health	$2.35B	2.73	$128.37M	-$0.63	N/A
Astrana Health	$3.18B	0.67	$22.49M	$0.82	46.32

Hims & Hers Health presently has a consensus price target of $32.43, indicating a potential upside of 18.18%. Astrana Health has a consensus price target of $49.43, indicating a potential upside of 30.14%. Given Astrana Health's stronger consensus rating and higher possible upside, analysts plainly believe Astrana Health is more favorable than Hims & Hers Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hims & Hers Health	1 Sell rating(s)	12 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.13
Astrana Health	0 Sell rating(s)	2 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.78

In the previous week, Hims & Hers Health had 31 more articles in the media than Astrana Health. MarketBeat recorded 32 mentions for Hims & Hers Health and 1 mentions for Astrana Health. Astrana Health's average media sentiment score of 1.89 beat Hims & Hers Health's score of 0.17 indicating that Astrana Health is being referred to more favorably in the news media.

Company	Overall Sentiment
Hims & Hers Health	Neutral
Astrana Health	Very Positive

Astrana Health has a net margin of 1.05% compared to Hims & Hers Health's net margin of -5.51%. Astrana Health's return on equity of 10.30% beat Hims & Hers Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hims & Hers Health	-5.51%	-6.51%	-1.20%
Astrana Health	1.05%	10.30%	3.67%

Summary

Astrana Health beats Hims & Hers Health on 11 of the 16 factors compared between the two stocks.

How does Astrana Health compare to RadNet?

Astrana Health (NASDAQ:ASTH) and RadNet (NASDAQ:RDNT) are both mid-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, profitability, earnings, analyst recommendations, risk, institutional ownership and media sentiment.

Astrana Health currently has a consensus target price of $49.43, suggesting a potential upside of 30.14%. RadNet has a consensus target price of $90.00, suggesting a potential upside of 19.22%. Given Astrana Health's higher possible upside, equities analysts plainly believe Astrana Health is more favorable than RadNet.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Astrana Health	0 Sell rating(s)	2 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.78
RadNet	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	2 Strong Buy rating(s)	2.89

Astrana Health has higher revenue and earnings than RadNet. RadNet is trading at a lower price-to-earnings ratio than Astrana Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Astrana Health	$3.18B	0.67	$22.49M	$0.82	46.32
RadNet	$2.04B	2.91	-$18.65M	-$0.27	N/A

Astrana Health has a beta of 0.9, meaning that its stock price is 10% less volatile than the broader market. Comparatively, RadNet has a beta of 1.41, meaning that its stock price is 41% more volatile than the broader market.

In the previous week, RadNet had 7 more articles in the media than Astrana Health. MarketBeat recorded 8 mentions for RadNet and 1 mentions for Astrana Health. Astrana Health's average media sentiment score of 1.89 beat RadNet's score of 0.55 indicating that Astrana Health is being referred to more favorably in the media.

Company	Overall Sentiment
Astrana Health	Very Positive
RadNet	Positive

52.8% of Astrana Health shares are held by institutional investors. Comparatively, 77.9% of RadNet shares are held by institutional investors. 20.3% of Astrana Health shares are held by company insiders. Comparatively, 5.1% of RadNet shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Astrana Health has a net margin of 1.05% compared to RadNet's net margin of -0.93%. Astrana Health's return on equity of 10.30% beat RadNet's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Astrana Health	1.05%	10.30%	3.67%
RadNet	-0.93%	2.61%	0.91%

Summary

Astrana Health beats RadNet on 11 of the 17 factors compared between the two stocks.

How does Astrana Health compare to LifeStance Health Group?

LifeStance Health Group (NASDAQ:LFST) and Astrana Health (NASDAQ:ASTH) are both mid-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, valuation, analyst recommendations, institutional ownership, media sentiment, profitability, risk and earnings.

85.5% of LifeStance Health Group shares are held by institutional investors. Comparatively, 52.8% of Astrana Health shares are held by institutional investors. 3.5% of LifeStance Health Group shares are held by company insiders. Comparatively, 20.3% of Astrana Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

In the previous week, LifeStance Health Group had 16 more articles in the media than Astrana Health. MarketBeat recorded 17 mentions for LifeStance Health Group and 1 mentions for Astrana Health. Astrana Health's average media sentiment score of 1.89 beat LifeStance Health Group's score of 0.89 indicating that Astrana Health is being referred to more favorably in the news media.

Company	Overall Sentiment
LifeStance Health Group	Positive
Astrana Health	Very Positive

LifeStance Health Group currently has a consensus price target of $12.88, indicating a potential downside of 0.73%. Astrana Health has a consensus price target of $49.43, indicating a potential upside of 30.14%. Given Astrana Health's stronger consensus rating and higher probable upside, analysts plainly believe Astrana Health is more favorable than LifeStance Health Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LifeStance Health Group	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.73
Astrana Health	0 Sell rating(s)	2 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.78

LifeStance Health Group has a net margin of 3.19% compared to Astrana Health's net margin of 1.05%. Astrana Health's return on equity of 10.30% beat LifeStance Health Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
LifeStance Health Group	3.19%	3.39%	2.33%
Astrana Health	1.05%	10.30%	3.67%

LifeStance Health Group has a beta of 1.22, meaning that its stock price is 22% more volatile than the broader market. Comparatively, Astrana Health has a beta of 0.9, meaning that its stock price is 10% less volatile than the broader market.

Astrana Health has higher revenue and earnings than LifeStance Health Group. Astrana Health is trading at a lower price-to-earnings ratio than LifeStance Health Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LifeStance Health Group	$1.42B	3.48	$9.66M	$0.13	99.77
Astrana Health	$3.18B	0.67	$22.49M	$0.82	46.32

Summary

Astrana Health beats LifeStance Health Group on 10 of the 17 factors compared between the two stocks.

Get Astrana Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ASTH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ASTH vs. The Competition

Export

Metric	Astrana Health	Healthcare Providers & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$2.12B	$9.84B	$7.17B	$12.85B
Dividend Yield	N/A	2.61%	2.57%	11.71%
P/E Ratio	46.32	33.53	274.94	25.33
Price / Sales	0.67	4.89	685.45	111.12
Price / Cash	13.50	125.15	76.65	51.52
Price / Book	2.70	5.29	10.33	6.20
Net Income	$22.49M	$313.25M	$3.50B	$358.50M
7 Day Performance	-1.27%	-1.26%	-3.32%	-2.35%
1 Month Performance	6.12%	-0.98%	-0.41%	-2.77%
1 Year Performance	27.32%	15.13%	19.21%	7.63%

Astrana Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ASTH Astrana Health	4.0864 of 5 stars	$37.98 -0.1%	$49.43 +30.1%	+27.3%	$2.12B	$3.18B	46.32	3,000	Positive News
HNGE Hinge Health	3.6004 of 5 stars	$92.79 +0.5%	$101.93 +9.9%	+54.2%	$7.45B	$587.86M	72.49	1,437	News Coverage Analyst Forecast Insider Trade
CHE Chemed	4.4122 of 5 stars	$519.96 +0.0%	$530.75 +2.1%	+15.5%	$6.79B	$2.60B	26.12	15,811	Positive News
HIMS Hims & Hers Health	2.7106 of 5 stars	$28.09 +1.4%	$32.50 +15.7%	-50.5%	$6.47B	$2.58B	N/A	2,442	Trending News Analyst Forecast
RDNT RadNet	3.1668 of 5 stars	$71.97 -2.4%	$90.00 +25.1%	+2.0%	$5.80B	$2.27B	N/A	11,264	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ASTH) was last updated on 9/13/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Astrana Health (ASTH) Competitors

ASTH vs. HNGE, CHE, HIMS, RDNT, and LFST

How does Astrana Health compare to Hinge Health?

Summary

How does Astrana Health compare to Chemed?

Summary

How does Astrana Health compare to Hims & Hers Health?

Summary

How does Astrana Health compare to RadNet?

Summary

How does Astrana Health compare to LifeStance Health Group?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ASTH vs. The Competition

Astrana Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Astrana Health (ASTH) Competitors

ASTH vs. HNGE, CHE, HIMS, RDNT, and LFST

How does Astrana Health compare to Hinge Health?

Is ASTH or HNGE more profitable?

Which has more volatility and risk, ASTH or HNGE?

Which has better valuation & earnings, ASTH or HNGE?

Do analysts rate ASTH or HNGE?

Do institutionals & insiders hold more shares of ASTH or HNGE?

Does the media prefer ASTH or HNGE?

Summary

How does Astrana Health compare to Chemed?

Which has more volatility & risk, CHE or ASTH?

Does the media favor CHE or ASTH?

Which has better earnings and valuation, CHE or ASTH?

Is CHE or ASTH more profitable?

Do analysts prefer CHE or ASTH?

Do institutionals & insiders believe in CHE or ASTH?

Summary

How does Astrana Health compare to Hims & Hers Health?

Which has more risk & volatility, HIMS or ASTH?

Do institutionals and insiders believe in HIMS or ASTH?

Which has preferable earnings and valuation, HIMS or ASTH?

Do analysts recommend HIMS or ASTH?

Does the media refer more to HIMS or ASTH?

Is HIMS or ASTH more profitable?

Summary

How does Astrana Health compare to RadNet?

Do analysts rate ASTH or RDNT?

Which has higher earnings & valuation, ASTH or RDNT?

Which has more risk & volatility, ASTH or RDNT?

Does the media prefer ASTH or RDNT?

Do institutionals & insiders hold more shares of ASTH or RDNT?

Is ASTH or RDNT more profitable?

Summary

How does Astrana Health compare to LifeStance Health Group?

Do insiders & institutionals believe in LFST or ASTH?

Does the media favor LFST or ASTH?

Do analysts recommend LFST or ASTH?

Is LFST or ASTH more profitable?

Which has more volatility and risk, LFST or ASTH?

Which has stronger valuation and earnings, LFST or ASTH?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ASTH vs. The Competition

Astrana Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools